Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
Gerresheimer buys majority stake in Shuangfeng Group
5/31/2006
BEIJING (XFN-Asia) - Germany's Gerresheimer Group said it has bought a majority interest in Chinese pharmaceutical packager Shuangfeng Group.
Gerresheimer, which makes pharmaceutical and cosmetics packaging, did not disclose the value or size of the stake.
However, a company statement said the acquisition allows it to enter the Chinese market for tubular glass packaging for the first time and to develop a base for targeted transfers of products to China and/or servicing of new low-price market segments.
The statement noted that an extra plant is being built on a greenfield site to accelerate expansion plans.
Gerresheimer said the transaction will result in a further substantial improvement in its world market position and cost situation.
At the end of 2005, Gerresheimer also acquired a 45.7 pct share in the Chinese moulded glass specialist, Beijing Wheaton - now known as Beijing Gerresheimer.
Gerresheimer has 21 production locations in Europe, America and Asia, and employs more than 5,700 people around the world. Global sales total more than 630 mln eur, according to the statement.
Shuangfeng employs 670 people in two locations, manufacturing around 800 mln pharma vials, predominantly for the domestic market.
The acquisition is subject to approval by the Chinese authorities, which is expected in the next few weeks, the statement said.
Relate News
more
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit